Oppenheimer reiterates an 'Outperform' on Gilead Sciences (NASDAQ: GILD) price target of $60.00.

Analyst, David Ferreiro, said, "The FDA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE